KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Total Non-Current Liabilities (2018 - 2022)

Progyny (PGNY) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $135.9 million as the latest value for Q1 2022.

  • Quarterly Total Non-Current Liabilities rose 24.58% to $135.9 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $135.9 million through Mar 2022, up 24.58% year-over-year, with the annual reading at $106.2 million for FY2021, 23.39% up from the prior year.
  • Total Non-Current Liabilities for Q1 2022 was $135.9 million at Progyny, up from $106.2 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $135.9 million in Q1 2022, with the low at $25.6 million in Q4 2018.
  • Average Total Non-Current Liabilities over 5 years is $83.3 million, with a median of $96.2 million recorded in 2020.
  • The sharpest move saw Total Non-Current Liabilities soared 138.1% in 2020, then rose 23.39% in 2021.
  • Over 5 years, Total Non-Current Liabilities stood at $25.6 million in 2018, then surged by 41.19% to $36.2 million in 2019, then skyrocketed by 138.1% to $86.1 million in 2020, then rose by 23.39% to $106.2 million in 2021, then increased by 27.92% to $135.9 million in 2022.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $135.9 million, $106.2 million, and $112.1 million for Q1 2022, Q4 2021, and Q3 2021 respectively.